Elcubragistat

N/A

Report date: 2026/02/16 20:01:25
NME

Base Information

Drug NameElcubragistat
Drug Alias NameABX-1431ABX-1431 HClLu-AG06466Lu AG-06466Lu-AG-06466 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoglyceride lipase inhibitors
TargetsMonoglyceride lipase
Therapy Area/IndicationsDiabetic peripheral neuropathyStress Disorders, Post-TraumaticAccidental Injuries +[15] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPoland +[8] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbide Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesH. Lundbeck A/S
Inactive CompaniesAbide Therapeutics Inc
Active IndicationsStress Disorders, Post-Traumatic
Inactive IndicationsDiabetic peripheral neuropathyAccidental InjuriesDyspepsia +[14] 

Other Information

ATC CodeN/A
Related LinksN/A